Create
Log in
Enquire now
TILT Biotherapeutics
TILT Biotherapeutics is a developer of gene therapies for cancer founded in 2013 by Akseli Hemminki.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
CEO
Akseli Hemminki
0
Company Operating Status
Active
COO
Aino Kalervo
Country
Finland
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Date Incorporated
2013
Email Address
bd@tiltbio.com
0
Facebook URL
@tiltbiotherapeutics
Founded Date
2013
Founder
Akseli Hemminki
0
Full Address
Tukholmankatu 8 B, Biomedicum 2B, (2nd floor) 00290 Helsinki, Finland.
0
Industry
Internal medicine
Cell therapy
Stem cell
Biopharmaceutical
Biomedical engineering
Oncolytic virus
Medicine
Technology
Biology
Biotechnology
•••
Investors
Lifeline Ventures
Stephens Industries
Tesi
European Innovation Council
Latest Funding Round Date
May 13, 2025
February 7, 2023
Latest Funding Round Amount (USD)
25,600,000
11,000,000
Latest Funding Type
Series B
Series A
LinkedIn URL
@company/tilt-biotherapeutics-ltd/about
Location
Finland
Helsinki
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
2
Pitchbook URL
pitchbook.com/profiles...114396-22
Total Funding Amount (USD)
47,600,000
22,000,000
Official Website
tiltbio.com
Find more companies like TILT Biotherapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE